OraSure Technologies, Inc. (OSUR): Price and Financial Metrics

OraSure Technologies, Inc. (OSUR)

Today's Latest Price: $12.92 USD

0.06 (0.47%)

Updated Jan 15 4:00pm

Add OSUR to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 185 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

OSUR Stock Summary

  • The price/operating cash flow metric for Orasure Technologies Inc is higher than 99.56% of stocks in our set with a positive cash flow.
  • For OSUR, its debt to operating expenses ratio is greater than that reported by only 8.85% of US equities we're observing.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.12 for Orasure Technologies Inc; that's greater than it is for only 9.22% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Orasure Technologies Inc, a group of peers worth examining would be SCWX, SHSP, APDN, INVE, and STRM.
  • OSUR's SEC filings can be seen here. And to visit Orasure Technologies Inc's official web site, go to www.orasure.com.

OSUR Stock Price Chart Interactive Chart >

Price chart for OSUR

OSUR Price/Volume Stats

Current price $12.92 52-week high $19.75
Prev. close $12.86 52-week low $5.23
Day low $12.72 Volume 697,900
Day high $13.25 Avg. volume 1,094,550
50-day MA $12.18 Dividend yield N/A
200-day MA $13.21 Market Cap 926.79M

OraSure Technologies, Inc. (OSUR) Company Bio

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company was founded in 1979 and is based in Bethlehem, Pennsylvania.

OSUR Latest News Stream

Event/Time News Detail
Loading, please wait...

OSUR Latest Social Stream

Loading social stream, please wait...

View Full OSUR Social Stream

Latest OSUR News From Around the Web

Below are the latest news stories about Orasure Technologies Inc that investors may wish to consider to help them evaluate OSUR as an investment opportunity.

Aphria (APHA) Looks Good: Stock Adds 6% in Session

Aphria (APHA) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Yahoo | January 14, 2021

OraSure Technologies Announces 2021 Annual Meeting Date

BETHLEHEM, Pa., Jan. 08, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) today announced that its 2021 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 18, 2021. The record date for the Meeting will be March 26, 2021. Only stockholders of record as of the close of business on the record date will be entitled to vote at the 2021 Annual Meeting, or any adjournment(s) or postponement(s) of the Meeting. This will be a completely virtual meeting, conducted as a live webcast. Further details regarding the Meeting will be provided at a later date. About OraSure TechnologiesOraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. OraSure, t...

Yahoo | January 8, 2021

OraSure Technologies to Present at the 39th Annual J.P. Morgan Healthcare Conference

BETHLEHEM, Pa., Jan. 05, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the 39th Annual J.P. Morgan Healthcare Conference. The conference will be simultaneously webcast over the Internet. Dr. Tang is scheduled to speak on January 12, 2021, at approximately 2:50 PM Eastern Standard Time (11:50 PM Pacific Time). Interested investors can access the live webcast of the presentation by going to OraSure Technologies’ web site, www.orasure.com and clicking on the Investor Info link. A replay of the webcast will be available on OraSure Technologie...

Yahoo | January 5, 2021

Global Preliminary Screening Tests Market Size, Industry Status and Growth opportunities for Leading Players-Abbott, BD, Bio-rad Laboratories, Inc., Cepheid., Hologic Inc., Meridian Bioscience, Inc., OraSure Technologies, Inc

The demand for preliminary screening tests is projected to achieve market share over the 2020 to 2027 forecast period. Data Bridge Market Research analyses the demand in the projected timeframe to expand at a CAGR of 7.11 percent. Preliminary Screening

OpenPR | December 28, 2020

OraSure’s OMNIgene®·ORAL Device Included in EUA Amendment Granted to 3B BlackBio Biotech India for SARS-CoV-2 Test

OTTAWA, Dec. 23, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that its OMNIgene®·ORAL (OM/OME-505) collection device was included in the U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) amendment granted to 3B BlackBio Biotech, one of the leading suppliers and developers for RT-PCR diagnostic assays in India. This is the seventh customer EUA that includes a collection device from the company’s DNA Genotek subsidiary. This EUA amendment will allow 3B BlackBio Biotech’s North American distributor, Genophyll Enterprises, to expand saliva COVID-19 PCR-based viral diagnostic testing across the U.S. as well...

Yahoo | December 23, 2020

Read More 'OSUR' Stories Here

OSUR Price Returns

1-mo 16.40%
3-mo -12.53%
6-mo -24.22%
1-year 57.18%
3-year -40.49%
5-year 130.30%
YTD 22.06%
2020 31.82%
2019 -31.25%
2018 -38.07%
2017 114.81%
2016 36.34%

Continue Researching OSUR

Here are a few links from around the web to help you further your research on Orasure Technologies Inc's stock as an investment opportunity:

Orasure Technologies Inc (OSUR) Stock Price | Nasdaq
Orasure Technologies Inc (OSUR) Stock Quote, History and News - Yahoo Finance
Orasure Technologies Inc (OSUR) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7942 seconds.